Gene Therapy

Gene Therapy is a premier international journal dedicated to the rapid publication of high-quality research in the field of molecular medicine and genetic intervention. Published by Springer Nature, the journal serves as a vital platform for advancing the understanding and clinical application of gene-based therapeutics. Its scope encompasses the full spectrum of gene therapy, from fundamental molecular mechanisms and vector development to preclinical studies and translational clinical trials. Key topics include viral and non-viral vector design, gene editing technologies (such as CRISPR/Cas9), stem cell gene therapy, oncolytic virotherapy, and the treatment of inherited genetic disorders, cancers, and cardiovascular diseases. The journal features a diverse array of article types, including original research articles, comprehensive reviews, brief communications, and timely perspectives that highlight emerging trends and critical challenges in the field. With a 2026 Impact Factor of 5.900 and a distinguished JCR Quartile ranking of Q1, Gene Therapy is widely recognized as a leading authority in its discipline, consistently attracting rigorous, impactful work from academic, clinical, and industrial researchers worldwide. Its target audience includes molecular biologists, geneticists, pharmacologists, clinical investigators, and biotechnology professionals seeking cutting-edge insights into the translation of genetic science into viable therapies. Notably, the journal offers an open access publishing option, ensuring broad dissemination of significant findings. Through its stringent peer review and commitment to excellence, Gene Therapy remains an essential resource for shaping the future of precision medicine.